Table 4.

Adjusted odds ratios (AORs) from the random effects models for the intervention vs. usual care group on affirmative responses At 12 weeks

		At 52 weeks		Crude Adjusted
		Crude	Adjusted	Crude	Adjusted
Patient was on guideline-concordant pharmacotherapy	AOR 95 % CI	1.04 (0.93, 1.16)	1.03 (0.91, 1.17)	1.07 (0.96, 1.19)	1.06 (0.93, 1.21)
Patient recalled receiving a letter with their DXA results	AOR 95 % CI	3.10*** (2.66, 3.63)	3.14*** (2.71, 3.63)	N/A
Patient correctly identified the results of their baseline DXA	AOR 95 % CI	1.44*** (1.29, 1.62)	1.47*** (1.31, 1.64)	1.26** (1.10, 1.44)	1.27** (1.11, 1.45)
Patient reported having contact with their provider after their DXA	AOR 95 % CI	1.02 (0.92, 1.12)	1.01 (0.91, 1.12)	1.21* (1.05, 1.40)	1.21* (1.05, 1.39)
Patient discussed their DXA results with their provider	AOR 95 % CI	1.15* (1.02, 1.30)	1.13 (1.01, 1.27)	1.22** (1.09, 1.37)	1.24*** (1.11, 1.39)

The covariates that were adjusted for included clinical site, patient age, sex, race, education, self-rated health, COPD, depression, smoking status, alcohol use, weight-bearing exercise, fractures after age 40, parental hip fractures after age 50, prior DXA testing, index FRAX risk, prior diagnoses for osteopenia or osteoporosis, and current or former osteoporosis medication use

^*p < 0.025,

^**p < 0.005,

^***p < 0.0005